SVF ENDURANCE (CAYMAN) LTD sold 2.2% of their position (330.21K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $2.06M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/22/2025ACC: 0001493152-25-018917
10% Owner
Since Oct 2019
-330.21K
Net shares
Net seller
$2.06M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
330.21K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−220.53K
Price / share
$6.20
Trade value
$1.37M
% of position
1.4%
10/20/2025
15.34M→15.12M
Common Stock
Indirect
Shares
−109.67K
Price / share
$6.30
Trade value
$690.97K
% of position
0.7%
10/21/2025
15.12M→15.01M
Total
Net shares
−330.21K
Net value
-$2.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/20/2025 | S · Sale | −220.53K | $6.20 | $1.37M | 1.4% | 15.34M | 15.12M |
| Common Stock Indirect | 10/21/2025 | S · Sale | −109.67K | $6.30 | $690.97K | 0.7% | 15.12M | 15.01M |
| Total | −330.21K | -$2.06M | ||||||
Derivative Transactions0
No derivative transactions reported